Who we are
Cure KARS – Laia Foundation was founded in 2025 by Almudena Velasco and Pablo Garrigós after their daughter Laia was diagnosed with a KARS mutation at the age of 9 months. After reaching out to several families, other patient organisations and researchers around the globe, Pablo and Almudena understood that neither a cure nor treatment existed for their child. Thus, they committed to working, in collaboration with scientists, to support research. The Cure KARS – Laia foundation aspires to stimulate research that will yield effective treatments and ultimately a cure for the KARS1 mutation.
Independent Scientific Advisory Board
-
Herminia Argente
Neurologist
-
Maria Victoria Cascajo Almenara
CIBERER-CABD-UPO Researcher
-
Barbara Christine Vona
Human geneticist
-
Maria Cécile Nassonge
Neuropediatrician
-
Albert Quintana
ICREA Academy Researcher
Co-Founders and Board
-
Almudena Velasco
Co-founder and President
-
Pablo Garrigós
Co-founder and treasurer
-
Jordi Garrigós
Secretary General
Advisory committee
-
Joanne Small-Greenall
Community Engagement